Minocyclin in Ulcerative Colitis as Added on Therapy

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

January 20, 2027

Study Completion Date

August 20, 2028

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

Mesalazine

Mesalamine, also known as 5-aminosalicylic acid (5-ASA), is a medication used to treat ulcerative colitis. It is usually used to induce or maintain remission of mildly to moderately active ulcerative colitis

DRUG

Minocycline

Minocycline is a tetracycline antibiotic medication used to treat a number of bacterial infections such as pneumonia. It is generally less preferred than the tetracycline doxycycline. Minocycline is also used for the treatment of acne and rheumatoid arthritis.

Trial Locations (1)

7650001

RECRUITING

Faculty of Medicine, Mansoura University, Al Mansurah

All Listed Sponsors
collaborator

Amira Fawzy Mohamed Mashaly, Clinical Pharmacy Demonstrator, Faculty of Pharmacy- Horus University

UNKNOWN

collaborator

Tanta University

OTHER

collaborator

Mounir Hussein Bahgat Internal Medicine Department Mansoura University

UNKNOWN

lead

Mostafa Bahaa

OTHER